If the presence of functional ERs is so important for tissue invasion in several breast tumor types, a plausible question is whether the efficacy of conventional hormonal therapy is compromised in patients with dysfunctional ERs (those patients with the ER+PgR− tumor phenotype). Here, PGR is linked to breast neoplasm.